Published in AJNR Am J Neuroradiol on February 01, 2007
Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One (2012) 1.15
Advances in the application of MRI to amyotrophic lateral sclerosis. Expert Opin Med Diagn (2010) 1.03
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol (2010) 1.00
The cortical signature of amyotrophic lateral sclerosis. PLoS One (2012) 0.99
G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial. PLoS One (2011) 0.95
25 years of neuroimaging in amyotrophic lateral sclerosis. Nat Rev Neurol (2013) 0.93
An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies. Neurodegener Dis (2015) 0.90
Patterns of spontaneous brain activity in amyotrophic lateral sclerosis: a resting-state FMRI study. PLoS One (2012) 0.90
Lessons of ALS imaging: Pitfalls and future directions - A critical review. Neuroimage Clin (2014) 0.87
Neuroimaging in amyotrophic lateral sclerosis. Neurotherapeutics (2011) 0.87
Brain atrophy and neuropsychological outcome after treatment of ruptured anterior cerebral artery aneurysms: a voxel-based morphometric study. Neuroradiology (2009) 0.86
Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One (2014) 0.85
Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment. BMC Neurosci (2014) 0.83
Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research. Neural Plast (2012) 0.83
Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis. Neurotherapeutics (2015) 0.83
Magnetic resonance imaging in amyotrophic lateral sclerosis. Neurol Res Int (2012) 0.82
What does imaging reveal about the pathology of amyotrophic lateral sclerosis? Curr Neurol Neurosci Rep (2015) 0.82
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS One (2013) 0.82
Right hemisphere dysfunction and emotional processing in ALS: an fMRI study. J Neurol (2010) 0.81
Mapping cortical degeneration in ALS with magnetization transfer ratio and voxel-based morphometry. PLoS One (2013) 0.81
Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniques. J Alzheimers Dis Parkinsonism (2014) 0.80
Agraphia in intellectually normal Japanese patients with ALS: omission of kana letters. J Neurol (2009) 0.79
Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci Rep (2016) 0.79
Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis. PLoS One (2014) 0.79
Disparate voxel based morphometry (VBM) results between SPM and FSL softwares in ALS patients with frontotemporal dementia: which VBM results to consider? BMC Neurol (2015) 0.79
The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review. BMC Neurol (2016) 0.78
Brain white matter shape changes in amyotrophic lateral sclerosis (ALS): a fractal dimension study. PLoS One (2013) 0.78
Microstructural white matter changes underlying cognitive and behavioural impairment in ALS--an in vivo study using DTI. PLoS One (2014) 0.78
Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis. PLoS One (2015) 0.77
Side of limb-onset predicts laterality of gray matter loss in amyotrophic lateral sclerosis. Biomed Res Int (2014) 0.76
Voxel-Wise Meta-Analysis of Gray Matter Changes in Amyotrophic Lateral Sclerosis. Front Aging Neurosci (2016) 0.76
Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state. Eur J Neurol (2016) 0.76
Relationship between Clinical Parameters and Brain Structure in Sporadic Amyotrophic Lateral Sclerosis Patients According to Onset Type: A Voxel-Based Morphometric Study. PLoS One (2017) 0.75
Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis. EJNMMI Res (2017) 0.75
Brain Parenchymal Fraction: A Relatively Simple MRI Measure to Clinically Distinguish ALS Phenotypes. Biomed Res Int (2015) 0.75
Cerebral Degeneration in Amyotrophic Lateral Sclerosis Revealed by 3-Dimensional Texture Analysis. Front Neurosci (2016) 0.75
Quantitative brain MR imaging in amyotrophic lateral sclerosis. MAGMA (2011) 0.75
Neural correlates of cognitive decline in ALS: an fNIRS study of the prefrontal cortex. Cogn Neurosci (2013) 0.75
Computer-based 3D MR imaging analysis in amyotrophic lateral sclerosis: common and specific factors among studies. AJNR Am J Neuroradiol (2007) 0.75
Frontal assessment battery and frontal atrophy in amyotrophic lateral sclerosis. Brain Behav (2017) 0.75
Regional assessment of brain atrophy: a novel approach to achieve a more complete picture of tissue damage associated with central nervous system disorders? AJNR Am J Neuroradiol (2007) 0.75
Dissociation of Structural and Functional Integrities of the Motor System in Amyotrophic Lateral Sclerosis and Behavioral-Variant Frontotemporal Dementia. J Clin Neurol (2016) 0.75
Brain Parenchymal Fraction in Healthy Adults-A Systematic Review of the Literature. PLoS One (2017) 0.75
The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell (1999) 8.07
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A (1980) 6.31
TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell (2001) 4.60
Genetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis (2000) 3.01
The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol (2000) 2.71
Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet (2000) 2.67
A two-site monoclonal antibody ELISA for the quantification of the major Dermatophagoides spp. allergens, Der p I and Der f I. J Immunol Methods (1989) 2.56
Numbers of Giardia in the feces of infected children. Am J Trop Med Hyg (1975) 2.38
The human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene (1995) 2.19
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol (2000) 2.19
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology (2010) 2.14
Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J Biol Chem (2001) 2.09
Studies of electroimmunodiffusion: immunochemical quantitation of proteins in dilute solutions. Immunochemistry (1969) 2.05
Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine (1992) 1.97
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.91
The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proc Natl Acad Sci U S A (1998) 1.87
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology (2010) 1.85
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult Scler (2005) 1.81
Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J Neurosci (2005) 1.78
Electrocautery as a factor in seroma formation following mastectomy. Am J Surg (1998) 1.75
Physiological outcomes of aerobic exercise training in hemiparetic stroke patients. Stroke (1995) 1.73
Thoracoscopic repair of H-type tracheoesophageal fistula in the newborn: a technical case report. J Pediatr Surg (2004) 1.72
The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler (2006) 1.71
Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler (1997) 1.65
Clinical phenotype associated with terminal 2q37 deletion. Clin Genet (1995) 1.63
1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem (2001) 1.62
Cyclic AMP stabilizes a class of developmentally regulated Dictyostelium discoideum mRNAs. Nature (1983) 1.61
Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J (1993) 1.59
Guillain-Barré syndrome after exogenous gangliosides in Italy. BMJ (1993) 1.52
Direct induction of Dictyostelium prestalk gene expression by DIF provides evidence that DIF is a morphogen. Cell (1987) 1.52
Mononuclear cell chemoattractant activity from cultured arterial smooth muscle cells. Exp Mol Pathol (1982) 1.51
Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy. Epilepsia (1999) 1.50
Effects of the remote C fibres stimulation induced by capsaicin on the blink reflex in chronic migraine. Cephalalgia (2007) 1.49
Clinical-angiographic correlations in 132 patients with megadolichovertebrobasilar anomaly. Neuroradiology (1984) 1.48
Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology (1986) 1.48
Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry (2005) 1.47
Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. The Groupe d'Etude du Pronostic de l'Infarctus du Myocarde (GREPI) Eur Heart J (1997) 1.47
Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost (2007) 1.46
Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology. Ital J Neurol Sci (1997) 1.46
A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy. Neuromuscul Disord (2007) 1.45
In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res (2000) 1.43
Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage free serum prostatic specific antigen. BJU Int (1999) 1.42
The "mirror-neuron system" in MS: A 3 tesla fMRI study. Neurology (2007) 1.42
Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy. Radiother Oncol (1998) 1.42
Emergencies in hereditary haemorrhagic telangiectasia. QJM (2005) 1.41
The fecal microbial population in the irritable bowel syndrome. Microbiologica (1982) 1.40
Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood (2001) 1.39
Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut (2000) 1.39
The murine homolog of human Nectin1delta serves as a species nonspecific mediator for entry of human and animal alpha herpesviruses in a pathway independent of a detectable binding to gD. Proc Natl Acad Sci U S A (2000) 1.38
Prevalence of dust mites in the homes of people with asthma living in eight different geographic areas of the United States. J Allergy Clin Immunol (1992) 1.34
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS. Neurology (1999) 1.31
Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia (2003) 1.29
Comparison of Candida-delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer. Int Arch Allergy Appl Immunol (1974) 1.29
Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate. Eur J Immunol (1986) 1.25
Human nectin3/PRR3: a novel member of the PVR/PRR/nectin family that interacts with afadin. Gene (2000) 1.24
Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology (2002) 1.23
Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol (1987) 1.22
Fibromyalgia comorbidity in primary headaches. Cephalalgia (2009) 1.18
Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry. J Virol (2001) 1.15
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene (2006) 1.15
Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry (1995) 1.13
Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia (2007) 1.13
A family study on primary blepharospasm. J Neurol Neurosurg Psychiatry (2006) 1.13
Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer (1986) 1.12
Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia. Int J Radiat Biol (2001) 1.11
Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage (2002) 1.11
Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler (2006) 1.10
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology (2005) 1.10
CT and MR studies of methylmalonic acidemia. AJNR Am J Neuroradiol (1991) 1.09
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. Eur J Neurol (2012) 1.09
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. Ann Neurol (2009) 1.09
Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group. J Neurol Neurosurg Psychiatry (1998) 1.09
[A comparative study of the feasibility and limits of ambulatory surgery in infants under and over one year of age]. Ann Chir (2004) 1.08
Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Int J Lab Hematol (2009) 1.08
Effect of disodium cromoglycate on certain passive cutaneous anaphylactic reactions. J Immunol (1969) 1.07
Population Densities of Meloidogyne incognita and Yield of Capsicum annuum. J Nematol (1985) 1.07
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia. Eur Neurol (1993) 1.07
Prevalence of basidiomycete allergy in the USA and Europe and its relationship to allergic respiratory symptoms. Allergy (1994) 1.06
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine (1992) 1.06
Cyclic AMP-responsive element binding protein in brain mitochondria. J Neurochem (1999) 1.06
Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun (1993) 1.06
Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J Biol Chem (1996) 1.06
Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry (2007) 1.05
Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation. J Neurol (1985) 1.04
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. Mult Scler (2002) 1.04
Disturbances of cardiac rhythm during anesthesia and surgery. JAMA (1971) 1.04
Measurement of IgG antibody and airborne antigen to control an industrial outbreak of hypersensitivity pneumonitis. J Occup Med (1983) 1.03
Comparison of murine and human nectin1 binding to herpes simplex virus glycoprotein D (gD) reveals a weak interaction of murine nectin1 to gD and a gD-dependent pathway of entry. Virology (2001) 1.03